UNDA 240

Manufacturer
Seroyal USA | SAN’UP
Effective date
2022-11-09
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 02:18:28

Label at a glance#

ProductUNDA 240
Active ingredientFILIPENDULA ULMARIA ROOT, SAGE, GENTIANA LUTEA ROOT, SAXIFRAGA GRANULATA FLOWERING TOP, EQUISETUM ARVENSE BRANCH
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients
Each drop contains:
Equisetum arvense (Common horsetail) Stem 6X
Gentiana lutea (Yellow gentian) Underground Parts 6X
Salvia officinalis (Garden sage) Leaf 6X
Saxifraga granulata Aerial Parts 6X
Spiraea ulmaria (Queen-of-themeadow) Underground Parts 6X

OTC - PURPOSE SECTION

Uses
For the temporary relief of symptoms associated with growing pains.

WARNINGS SECTION

Warnings
Stop use and ask a doctor if symptoms persist or worsen.

If pregnant or breastfeeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breastfeeding, ask a health professional before use.

OTHER SAFETY INFORMATION

Other information
Do not use if seal is missing or broken.
Store in a cool, dry place.

INACTIVE INGREDIENT SECTION

Inactive ingredients
Ethanol (beet), purified water

DOSAGE & ADMINISTRATION SECTION

Directions
Adults and adolescents (12 years and older)

Take 5 drops three times daily or as recommended by your healthcare practitioner.

Children (under 12 years)

Take under the direction of your healthcare practitioner.

INDICATIONS & USAGE SECTION

Uses
For the temporary relief of symptoms associated with growing pains.

Directions
Adults and adolescents (12 years and older)

Take 5 drops three times daily or as recommended by your healthcare practitioner.

Children (under 12 years)

Take under the direction of your healthcare practitioner.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

62106-1161-862106-1161-8

NDC 62106-1161-8

UNDA

numbered compounds

UNDA 240

Homeopathic Preparation

For the temporary relief of symptoms associated with growing pains.

Contains 31% Alcohol

0.7 fl oz (20 ml)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62106-1161-8UNDA 2401 in 1 CARTONLIQUID13
62106-1161-8UNDA 24020 mL in 1 BOTTLE, GLASSLIQUID203

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62106-1161UNDA 240 (EQUISETUM ARVENSE, GENTIANA LUTEA, SALVIA OFFICINALIS, SAXIFRAGA GRANULATA, SPIRAEA ULMARIA) LIQUID [SEROYAL USA]3Current NDC, Legacy NDC, 2 package rows20221110_43a3d9da-f7e9-2257-e054-00144ff8d46c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62106-116162106-1161-8

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UNDA 240EQUISETUM ARVENSE, GENTIANA LUTEA, SALVIA OFFICINALIS, SAXIFRAGA GRANULATA, SPIRAEA ULMARIASeroyal USA43a3d9da-f7e9-2257-e054-00144ff8d46c2022-11-09WarningsExact identifier
ndc (package): 62106-1161-8
ndc (product): 62106-1161
ndc11 (package): 62106116108
spl id: ed11e5b0-cdb0-1f9a-e053-2995a90a0f16
spl set id: 43a3d9da-f7e9-2257-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.